Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Louis Stanley Chupak is active.

Publication


Featured researches published by Louis Stanley Chupak.


Journal of Organic Chemistry | 2009

Palladium-Catalyzed Cross-Coupling Reactions of Benzyl Indium Reagents with Aryl Iodides

Louis Stanley Chupak; Joanna P. Wolkowski; Yves A. Chantigny

Herein described is an operationally simple procedure for generating benzyl indium species from readily available benzyl bromides and indium metal followed by in situ palladium-catalyzed coupling with aryl halides. The procedure provides diarylmethanes in modest to excellent yield and tolerates a variety of functional groups in both coupling partners.


Bioorganic & Medicinal Chemistry Letters | 2001

Isoxazolyl, oxazolyl, and thiazolylpropionic acid derivatives as potent α4β1 integrin antagonists

Allen J. Duplantier; Gretchen E Beckius; Robert J. Chambers; Louis Stanley Chupak; Teresa H. Jenkinson; Anne S. Klein; Kenneth G. Kraus; Elizabeth M. Kudlacz; Michael William Mckechney; Martin Pettersson; Carrie A Whitney; Anthony J. Milici

Abstract A series of isoxazolyl, oxazolyl, and thiazolylpropionic acid derivatives derived from LDV was found to be a potent antagonist of the α 4 β 1 integrin. The synthesis and SAR leading up to 3-[3-(1-{2-[3-methoxy-4-(3- o -tolyl-ureido)-phenyl]-acetylamino}-3-methyl-butyl)-isoxazol-5-yl]-propionic acid ( 22 ) are reported. In an allergic mouse model, compound 22 was efficacious delivered systemically (58% inhib @ 10 mg/kg, sc) as well as by intra-tracheal instillation (ED 50 =2 μg/kg).


Archive | 1995

Arylsulfonyl hydroxamic acid derivatives

Kim F. McClure; Mark C. Noe; Michael A. Letavic; Louis Stanley Chupak


Archive | 2002

Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases

Allen J. Duplantier; Louis Stanley Chupak; Anthony J. Milici; Wan F. Lau


Archive | 2005

Selective inhibition of aggrecanase in osteoarthritis treatment

Mark C. Noe; Michael A. Letavic; Louis Stanley Chupak; Kim F. McClure


Archive | 1999

Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors

Kim F. McClure; Mark C. Noe; Michael A. Letavic; Louis Stanley Chupak


Bioorganic & Medicinal Chemistry Letters | 2007

Synthesis and SAR of novel conformationally-restricted oxazolidinones possessing Gram-positive and fastidious Gram-negative antibacterial activity. Part 1: Substituted pyrazoles

Frederick E. Boyer; J.V.N. Vara Prasad; Allison L. Choy; Louis Stanley Chupak; Michael R. Dermyer; Qizhu Ding; Michael D. Huband; Wenhua Jiao; Takushi Kaneko; Vladimir Khlebnikov; Ji-Young Kim; Manjinder S. Lall; Samarendra N. Maiti; Karina Romero; Xiujuan Wu


Archive | 2002

Alkyne containing metalloproteinase inhibitors

Louis Stanley Chupak


Archive | 2004

Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents

Louis Stanley Chupak; Takushi Kaneko; Vara Prasad Venkata Nagendra Josyula; Martin Pettersson; Manjinder S. Lall; Susan Elizabeth Hagen; Frederick E. Boyer


Archive | 1999

Hydroxy pipecolate hydroxamic acid derivatives

Kim F. McClure; Mark C. Noe; Michael A. Letavic; Louis Stanley Chupak

Collaboration


Dive into the Louis Stanley Chupak's collaboration.

Researchain Logo
Decentralizing Knowledge